Page last updated: 2024-09-03

27-hydroxycholesterol and Triple Negative Breast Neoplasms

27-hydroxycholesterol has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Holly, JMP; Mashat, RM; Perks, CM; Zielinska, HA	1

Other Studies

1 other study(ies) available for 27-hydroxycholesterol and Triple Negative Breast Neoplasms

Article	Year
A Role for ER-Beta in the Effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on Breast Cancer Progression: Involvement of the IGF Signalling Pathway? Cells, 2021, 12-29, Volume: 11, Issue:1 Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholesterol, LDL; Disease Progression; Epithelial-Mesenchymal Transition; ErbB Receptors; Estrogen Receptor beta; Female; Humans; Hydroxycholesterols; Insulin-Like Growth Factor I; Metabolome; Neoplasm Invasiveness; Receptor, IGF Type 1; Signal Transduction; Triple Negative Breast Neoplasms	2021

Article

Year

A Role for ER-Beta in the Effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on Breast Cancer Progression: Involvement of the IGF Signalling Pathway?

Cells, 2021, 12-29, Volume: 11, Issue:1

Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholesterol, LDL; Disease Progression; Epithelial-Mesenchymal Transition; ErbB Receptors; Estrogen Receptor beta; Female; Humans; Hydroxycholesterols; Insulin-Like Growth Factor I; Metabolome; Neoplasm Invasiveness; Receptor, IGF Type 1; Signal Transduction; Triple Negative Breast Neoplasms

2021